Recorded Chinese product: 奋乃静注射液奋乃静注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

奋乃静是一种在国家药监局注册认定的药品。该药品含有主要成份奋乃静、奋乃静-b5378d08等成分。

该药品关联的活性成分包括:主要成份奋乃静Recorded Chinese composition: 主要成份奋乃静、奋乃静Fennai Jing。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:天津金耀氨基酸有限公司Chinese legal name: 天津金耀氨基酸有限公司。

您可以探索含有相同成分的其他药品:主要成份奋乃静-9cfdd773成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 奋乃静注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 主要成份奋乃静Recorded Chinese composition: Recorded Chinese name: 主要成份奋乃静, 奋乃静Fennai Jing.

Manufacturers recorded for this product: 天津金耀氨基酸有限公司Chinese legal name: 天津金耀氨基酸有限公司.

Explore other medicines containing the same ingredient: products containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 奋乃静注射液Recorded Chinese product: 奋乃静注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 1ml:5mg1 mL:5 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 天津金耀氨基酸有限公司Chinese legal name: 天津金耀氨基酸有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H12020988

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H12020988

Manufacturer

Chinese legal name: 天津金耀氨基酸有限公司

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H12020988

生产企业

天津金耀氨基酸有限公司

适应症

本品对幻觉妄想、思维障碍、淡漠木僵及焦虑激动等症状有较好的疗效。用于精神分裂症或其他精神病性障碍。因镇静作用较弱,对血压的影响较小。适用于器质性精神病、老年性精神障碍及儿童攻击性行为障碍。

用法用量

治疗精神分裂症,肌肉注射、一次5~10mg,一日2次。或静脉注射一次5mg,用氯化钠注射液稀释成0.5mg/ml,注射速度每分钟不超过1mg。待患者合作后改为口服。

不良反应

1. 主要有锥体外系反应,如:震颤、僵直、流涎、运动迟缓、静坐不能、急性肌张力障碍等。长期大量用药可引起迟发性运动障碍。2. 可引起血浆中泌乳素浓度增加,可能有关的症状为:溢乳、男子女性化乳房、月经失调、闭经。可出现口干、视物模糊、乏力、头晕、心动过速、便秘、出汗等。3. 少见的不良反应有体位性低血压,粒细胞减少症与中毒性肝损害。4. 偶见过敏性皮疹及恶性综合征。5. 可引起注射局部红肿、疼痛、硬结。

禁忌

基底神经节病变、帕金森病、帕金森综合征、骨髓抑制、青光眼、昏迷、对吩噻嗪类药过敏者。

注意事项

1. 患有心血管疾病(如心衰、心肌梗死、传导异常)应慎用。2. 出现迟发性运动障碍,应停用所有的抗精神病药。3. 出现过敏性皮疹及恶性综合征应立即停药并进行相应的处理。4. 肝、肾功能不全者应减量。5. 癫痫患者应慎用。6. 应定期检查肝功能与白细胞计数。7. 用药期间不宜驾驶车辆、操作机械或高空作业。

贮藏

密封,置阴凉处。

规格

1ml:5mg

证据Evidence

  • 批准文号: 国药准字H12020988
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.